FDA Clearance Tracker · P010014-S005
OXFORD MENISCAL UNICOMPARTMENTAL KNEE SYSTEM
Last checked: Nov 20, 2026Latest source record: Aug 3, 2007 (this decision)Source: openFDAMethods & limitations
Decided
Aug 3, 2007
Approved
Time to decision
640 days
Received Nov 1, 2005. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P010014-S005
- Device name
- OXFORD MENISCAL UNICOMPARTMENTAL KNEE SYSTEM
- Applicant
- Biomet Manufacturing Corp
- Applicant location
- Warsaw, IN
- Received
- Nov 1, 2005
- Decided
- Aug 3, 2007
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Express GMP Supplement
- Original approval
- P010014
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A STERILIZATION SITE LOCATED AT ISOTRON PLC, BERKSHIRE, UNITED KINGDOM.
Source documents
Other decisions for Biomet Manufacturing Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Oxford Cementless Partial Knee SystemPMA supplement
P010014-S105 · Decided Nov 22, 2024 · 536 days after receipt · Panel Track
Device type: Prosthesis, knee, femorotibial, unicompartmental, semi-constrained, metal/polymer, mobile bearing (NRA) · Orthopedic Surgery
K230540 · Decided Jul 25, 2023 · 148 days after receipt
Device type: System, Image Processing, Radiological (LLZ) · Radiology & Imaging
K214001 · Decided Mar 15, 2023 · 449 days after receipt
Device type: Shoulder Prosthesis, Reverse Configuration (PHX) · Orthopedic Surgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.